First mRNA Flu Vaccine Receives FDA Approval

Why it matters locally: The approval of the first mRNA flu vaccine will directly impact Virginia's public health initiatives and healthcare providers, including those operating under the Virginia Department of Health, as they prepare for the upcoming flu season and integrate this new technology into vaccination campaigns.

---

The Food and Drug Administration (FDA) approved an mRNA-based flu vaccine for use in the upcoming flu season. Moderna, the vaccine's developer, created this new immunization technology. This approval represents the first time an mRNA flu vaccine has received authorization from the FDA. The vaccine will become available to the public in time for the next seasonal influenza period.